The beta-amyloid protein precursor of Alzheimer disease has soluble derivatives found in human brain and cerebrospinal fluid.

AUTOR(ES)

Palmert, M R

RESUMO

In this study, we use antisera to synthetic beta-amyloid protein precursor (beta APP) peptides to identify, in human brain and cerebrospinal fluid (CSF), soluble approximately 125- and approximately 105-kDa derivatives of the beta APP that lack the carboxyl terminus of the full-length, membrane-associated forms. We show that the soluble approximately 125-kDa beta APP derivative contains the Kunitz protease inhibitor domain, whereas the approximately 105-kDa form does not, and we confirm that these two proteins are soluble beta APP derivatives by purifying each from human CSF and directly sequencing its amino terminus.

Documentos Relacionados

• Increased gene expression of Alzheimer disease beta-amyloid precursor protein in senescent cultured fibroblasts.
• Beta-amyloid gene dosage in Alzheimer's disease.
• Inflammatory processes induce beta-amyloid precursor protein changes in mouse brain.
• Decreased levels of soluble amyloid beta-protein precursor in cerebrospinal fluid of live Alzheimer disease patients.
• Complement activation by beta-amyloid in Alzheimer disease.